| Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases A Undas, RAS Ariëns Arteriosclerosis, thrombosis, and vascular biology 31 (12), e88-e99, 2011 | 575 | 2011 |
| Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation A Undas, KE Brummel, J Musial, KG Mann, A Szczeklik Circulation 103 (18), 2248-2253, 2001 | 355 | 2001 |
| Statins and blood coagulation A Undas, KE Brummel-Ziedins, KG Mann Arteriosclerosis, thrombosis, and vascular biology 25 (2), 287-294, 2005 | 341 | 2005 |
| Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia J Musial, A Undas, P Gajewski, M Jankowski, W Sydor, A Szczeklik International journal of cardiology 77 (2-3), 247-253, 2001 | 340 | 2001 |
| Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions A Undas, KE Brummel-Ziedins, KG Mann Blood 109 (6), 2285-2292, 2007 | 303 | 2007 |
| Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives A Undas, K Zawilska, M Ciesla-Dul, A Lehmann-Kopydłowska, ... Blood, The Journal of the American Society of Hematology 114 (19), 4272-4278, 2009 | 293 | 2009 |
| Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome A Undas, I Wiek, E Stêpien, K Zmudka, W Tracz Diabetes care 31 (8), 1590-1595, 2008 | 270 | 2008 |
| PlA2 Polymorphism of β3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular … A Undas, K Brummel, J Musial, KG Mann, A Szczeklik Circulation 104 (22), 2666-2672, 2001 | 263 | 2001 |
| Homocysteine and thrombosis: from basic science to clinical evidence A Undas, J Brożek, A Szczeklik Thrombosis and haemostasis 94 (11), 907-915, 2005 | 258 | 2005 |
| Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses F D'Ascenzo, M Bollati, F Clementi, D Castagno, B Lagerqvist, ... International journal of cardiology 167 (2), 575-584, 2013 | 234 | 2013 |
| Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress A Undas, K Szułdrzynski, E Stepien, J Zalewski, J Godlewski, W Tracz, ... Atherosclerosis 196 (2), 551-557, 2008 | 220 | 2008 |
| Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia A Szczeklik, J Musiał, A Undas, P Gajewski, P Góra, J Swadźba, ... Journal of the American College of Cardiology 33 (5), 1286-1293, 1999 | 198 | 1999 |
| Autoantibodies Against N-Homocysteinylated Proteins in Humans: Implications for Atherosclerosis A Undas, J Perła, M Łacinski, W Trzeciak, R Kazmierski, H Jakubowski Stroke 35 (6), 1299-1304, 2004 | 193 | 2004 |
| Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa A Szczeklik, A Undas, M Sanak, M Frołow, W Węgrzyn British Journal of Haematology 110 (4), 965-967, 2000 | 186 | 2000 |
| Homocysteine inhibits inactivation of factor Va by activated protein C A Undas, EB Williams, S Butenas, T Orfeo, KG Mann Journal of Biological Chemistry 276 (6), 4389-4397, 2001 | 173 | 2001 |
| Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect G Dangas, DA Smith, AH Unger, JH Shao, P Meraj, C Fier, AM Cohen, ... Thrombosis and haemostasis 83 (05), 688-692, 2000 | 165 | 2000 |
| Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects A Undas, J Brozek, M Jankowski, Z Siudak, A Szczeklik, H Jakubowski Arteriosclerosis, thrombosis, and vascular biology 26 (6), 1397-1404, 2006 | 160 | 2006 |
| Fibrin clot properties and their modulation in thrombotic disorders A Undas Thrombosis and haemostasis 112 (07), 32-42, 2014 | 158 | 2014 |
| Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 … G Gajos, P Rostoff, A Undas, W Piwowarska Journal of the American College of Cardiology 55 (16), 1671-1678, 2010 | 158 | 2010 |
| Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease A Undas, M Celinska‐Löwenhoff, T Löwenhoff, A Szczeklik Journal of Thrombosis and Haemostasis 4 (5), 1029-1036, 2006 | 152 | 2006 |
